Erytech Pharma

Erytech Pharma: Company Financial Information
 Company name  ERYTech Pharma SA    ISIN:  FR0011471135
 End of Fiscal Year:  31 December 2015    Founded Year:  2013

Erytech Pharma

(at previous day's close)
Market Cap. 6.18 m
Shares In Issue 7.92 m
Prev. Close 0.78
PE Ratio -0.36  
Dividend Yield - %
EPS – basic -2.16 c
Dividend PS - c
Dividend Cover -
Cash Flow PS -1.84 c
Return On Equity (ROE) -36.19 %
Operating Margin - %
PEG Factor -  
EPS Growth Rate - %
Dividend PS Growth Rate - %
Net Debt -39.76 m
Gross Gearing 11.08 %
Quick Assets 51.45 m
Net Working Cap 47.38 m
Intangibles / Fixed Assets - %
Turnover PS - c
Pre-Tax Profit PS -0.00 c
Retained Profit PS - c
Cash PS 576.03 c
Net Cash PS 505.08 c
Net Tangible Asset Value PS* - c
Net Asset Value PS 669.06 c
Spread 0.00 (0.58%)
*Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Erytech Pharma Balance Sheet (31 Dec 2015)

ERYP:liab eqERYP:assets

Erytech Pharma Share Price

Sample Period † High Low
1 week 0.67 0.82
4 weeks 0.67 0.96
12 weeks 0.29 1.36
1 year 0.29 1.36

Erytech Pharma (5 years)

Erytech Pharma Historic Returns

Period *  Open Change % Open Avg. Avg. Daily Vol [m] Total Vol. [m] VWAP
1 week 0.80 -0.02 -2.38 0.73 173,651.00 0.74
4 weeks 0.93 -0.15 -16.13 0.82 192,548.00 0.83
12 weeks 0.39 0.39 100.00 0.71 690,587.00 0.76
26 weeks 0.77 0.01 1.30 0.68 364,938.00 0.74
1 year 1.75 -0.97 -55.43 0.93 266,756.00 0.92
3 years 4.63 -3.85 -83.15 3.74 224,513.00 3.34
5 years 16.90 -16.12 -95.38 5.42 149,530.00 3.78
* periods calculated are whole weeks rather than calendar months

Erytech Pharma Key Management Ratio

Erytech Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio -0.05  
PE Ratio -0.36  
Tobin's Q Ratio -  
Tobin's Q Ratio (excl. intangibles) -  
Dividend Yield - %
Market-to-Book Ratio 0.12  
Price-to-Pre-Tax Profit PS -3,573.80  
Price-to-Retained Profit PS -  
Price-to-Cash Flow PS -0.42  
Price-to-Sales PS -  
Price-to-Net Tangible Asset Value PS -  
Price-to-Cash PS 0.00  
Net Working Capital PS 5.98  
Price Pct to Working Capital PS 0.13 %
Earnings Yield - %
Average PE -  
Years in Average PE -  
PE to PE average - %

Erytech Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio -677.15 %
Debt-to-Equity Ratio -0.84  
Debt-to-Equity Ratio (excl. Intgbl) -0.84  
Debt-to-Equity Market Value -6.43  
Net Gearing -75.02 %
Net Gearing (excl. Intangibles) -75.10 %
Gross Gearing 11.08 %
Gross Gearing (excl. Intangibles) 11.09 %
Gearing Under 1 Year 10.60 %
Gearing Under 1 Year (excl. Intgbl) 10.62 %
Assets / Equity 1.12  
Cash / Equity 0.97  
(Liquidity Ratios)
Net Working Capital to Total Assets 89.40 %
Current Ratio 1.30  
Quick Ratio (Acid Test) 1.27  
Liquidity Ratio 8.12  
Cash & Equiv / Current Assets 624.35 %
(Solvency Ratios)
Enterprise Value -392.04 m
Sales -  
CFO / Attributable Profit -  
CFO / Assets -0.00  
CFO / Debt -0.00  
Total Debt / Equity Market Value 0.95  
Total Debt / Sales -  
Total Debt / Pre-Tax Profit -340,702.06  
Total Debt 5.87 m
Total Debt / Net Current Assets 0.12 %
(Dodds – Graham Ratios)
3 yr Compound Earnings Growth - %
5 yr Compound Earnings Growth - %
10 yr Compound Earnings Growth - %
Earn drops > 5% in 10yrs -  
Beta (60-Mnth) Beta (36-Mnth)
- -
Alpha (60-Mnth) Alpha (36-Mnth)
- -

Erytech Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE) - %
Return On Assets (ROA) - %
Net Profit Margin - %
Assets Turnover -  
Return On Equity (ROE) -36.19 %
Return On Investment (ROI) - %
Dividend Payout Ratio - %
Plowback Ratio - %
Growth from Plowback Ratio - %
Net Income of Revenues - %
(Asset Utilisation Multiples)
Shareholders Equity Turnover -  
Fixed Assets Turnover -  
Current Assets Turnover -  
Net Working Capital Turnover -  
Inventory Turnover -  
(Other Operating Ratios)
Total Assets-to-Sales -  
Debtors-to-Sales - %
Debt Collection Period - Days

Erytech Pharma Dividends

Type Curr. Dividend Amount Period Start Period End Total Dividend Amount
Final EUR - 31 Dec 2014 31 Dec 2015 -
Final EUR - 31 Dec 2013 31 Dec 2014 -
Final EUR - 31 Dec 2012 31 Dec 2013 -
Final EUR - 31 Dec 2011 31 Dec 2012 -
Final EUR - 31 Dec 2010 31 Dec 2011 -

Erytech Pharma Fundamentals
  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Turnover - 100.00% - 100.00% - 100.00% - 100.00% m
Pre Tax Profit -2.98 -% -9.55 -% -10.40 -% -17.24 -% m
Attributable Profit - -% - -% - -% - -% m
Retained Profit - -% - -% - -% - -% m
Eps – Basic -0.39 -1.74 -1.51 -2.16
Eps – Diluted -0.39 -1.74 -1.51 -2.16
Dividends per Share - - - -

Erytech Pharma Balance Sheet

  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
ERYP:liab eqERYP:assets ERYP:liab eqERYP:assets ERYP:liab eqERYP:assets ERYP:liab eqERYP:assets
  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
ASSETS
fixed assets  Fixed assets - -% - -% - -% - -% m
intangibles  Intangibles 0.03 0.29% 0.01 0.08% 0.03 0.08% 0.06 0.12% m
fixed investments  Fixed Investments - -% - -% - -% - -% m
current assets - other  Current Assets – Other 1.12 11.09% 1.00 5.55% 1.27 3.12% 1.23 2.33% m
stocks  Stocks 0.12 1.14% 0.14 0.77% 0.20 0.49% 0.17 0.31% m
debtors  Debtors 1.00 9.85% 1.69 9.40% 2.12 5.23% 5.91 11.15% m
cash & securities  Cash & securities 7.88 77.63% 15.11 84.20% 36.99 91.09% 45.63 86.10% m
Other assets 0.08 0.79% 0.08 0.46% 0.08 0.20% 0.10 0.18% m
TOTAL 10.14 100.00% 17.95 100.00% 40.61 100.00% 53.00 100.00% m
LIABILITIES
creditors - short  Creditors – Short 7.48 -185.67% 3.51 25.87% 4.26 11.88% 5.62 11.93% m
creditors - long  Creditors – Long 6.05 -150.22% 0.85 6.24% 0.52 1.46% 0.25 0.53% m
TOTAL 13.53 -335.88% 4.36 32.11% 4.78 13.35% 5.87 12.46% m
EQUITY
Minority Interest 4.03 -100.00% -13.59 -100.00% -35.82 -100.00% -47.13 -100.00% m
Capital Reserves -4.03 100.00% 13.59 100.00% 35.82 100.00% 47.13 100.00% m
TOTAL -4.03 100.00% 13.59 100.00% 35.82 100.00% 47.13 100.00% m

Erytech Pharma Cash Flow Statement

31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Operating CF 0.61 -6.47 -7.25 -14.58
Investing CF -0.01 -0.29 -0.42 -0.28
Financial CF 5.05 14.00 29.54 23.52
Net change CF 5.65 7.24 21.88 8.66

Erytech Pharma Employee Data

31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Number of employees 39.00 36.00 44.00 55.00
Sales per employee - - - - m

Data supplied by
Your Recent History
EU
ERYP
Erytech Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230320 15:13:43